"I trust you as much as my own doctor” is a statement increasingly heard by pharmacists as patients are recognizing the ease of access and valuable role of the community pharmacist for their health care needs. Pharmacy was once a profession that required only a bachelor’s degree and focused primarily on the dispensing of medications, but with the production of new vaccinations and medications in recent decades, the pharmacist’s role has been revolutionized. This expanded role calls for updates to the extensive curriculum necessary for a doctor of pharmacy degree as the first professional degree and a new understanding of what exactly pharmacists can provide.
Over the past 20 years, pharmacists have continued to expand their scope of practice beyond dispensing by providing new services such as medication therapy management (MTM), immunizations, and point-of-care testing. The value of expanding the clinical role of the pharmacist was highlighted during the COVID-19 pandemic, when pharmacists cemented their role as a vital part of the health care team by answering the call and administering nearly 70% of all COVID-19 vaccines,1 as well as providing other services, such as testing for the virus. Now the only question is: What comes next for the role of the community pharmacist, and how can it be achieved?
About the Authors
Adam James, PharmD, is manager of immunization and clinical programs at Rite Aid, where he provides updates, education, and best practices on changes in policies, procedures, and recommendations.
Shelby Close, PharmD, is a Rite Aid manager in McKees Rocks, Pennsylvania.
By 2050, the world population is projected to increase to an astounding 10 billion people, with the number of individuals aged 60 years and older expected to triple.2 By 2030, the US will face a shortage of more than 125,000 physicians, which could affect care for the more than 60% of individuals with 2 or more chronic health conditions. In addition, life expectancy in the US continues to increase, meaning more physicians will be needed as the older population increases.3 Pharmacists will be able to ameliorate this physician deficit by providing point-of-care testing, preventive care, and even by prescribing. Community pharmacies are the front door to health care, and approximately 90% of Americans live within 5 miles of one.4 However, the pandemic revealed that the conventional pharmacy system of relying on pharmacists for to manually fill prescriptions is a model of the past that must advance in order to benefit the larger health care ecosystem.
The demand for clinical pharmacists is more prevalent than ever. Since the introduction of MTM and development of immunization training programs in the early 2000s, which helped pave the way for the current model of the clinical pharmacist,5 pharmacists have been ready to accept the expanded role. According to CDC data, nearly 38 million influenza vaccines were administered by an estimated 57,000 pharmacies in the United States during the 2023-2024 influenza season.6 In addition to vaccines, community pharmacists completed more than 2 million more MTM claims than in previous years. Sixty percent of Medicare beneficiaries are on a performance-based pharmacy payment plan, which relies on the engagement of pharmacists through MTM to improve quality measures. This need for clinical engagement amplifies the valuable impact pharmacists have on the health system.5
Furthermore, recent changes in state legislation also reflect the need for more clinically oriented pharmacists. Fifty-five bills expanding the capabilities of the pharmacist were passed and signed into law across 32 states in 2023, supporting efforts to allow pharmacists to assist with the future shortage of physicians. Featured in the passage of bills is the ability of pharmacists to provide HIV preexposure prophylaxis and services for sexually transmitted diseases, as well as contraceptive prescribing, broad-spectrum antibiotics prescribing with physician collaboration, expanded payment for pharmacist services, and provider status.7